Plus, why this drug may also be heart healthy.
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
51 readers recommended
25 readers recommended
A new study from Dr. Doug Melton’s team provides hope for the future of stem cell treatment in diabetes. But there’s still a long way to go.
26 readers recommended
Closed loop systems, stem cells, smart insulin, and more!
38 readers recommended
How safe and effective is Jardiance in people with type 1 diabetes?
34 readers recommended
Currently enrolling! How does the pill form of this drug class compare to injected GLP-1s?
36 readers recommended
Why the company decided against pursuing its type 2 GLP-1 drug Victoza to the FDA for use in type 1 diabetes.
39 readers recommended
My somewhat-impatient response to the recent New York Times article, “Some Older Patients Are Treated Not Wisely, but Too Much.”
33 readers recommended
Pivotal trial to start in early 2017. What does glucagon add to automated insulin delivery?
43 readers recommended
Plus, a massive $2 billion investment in new production facilities!
38 readers recommended
New trial aims to make U500 (more concentrated) insulin easier to take.
26 readers recommended
The DreaMed Pump Advisor, Glooko app, Nutshell, and MyStar DoseCoach.
21 readers recommended
Approved for those who can’t tolerate more statins – is this you?
24 readers recommended
Patients with high A1c levels could achieve greater blood glucose control from the start.
22 readers recommended
A six-month study of Diasome Pharmaceuticals’ HDV Insulin in Type 1 Diabetes
33 readers recommended
Public workshop scheduled at FDA for August 29, 2016. Get involved!
29 readers recommended
Use 4 mm needles, rotate injection sites, and more – why the little stuff matters
37 readers recommended
What are the implications for other injected GLP-1 agonist drugs?
51 readers recommended
Why Novo Nordisk and Sanofi’s combination drugs are potential gamechangers for type 2 diabetes.
73 readers recommended
less risk of diabetes complications, lower A1c, improved weight loss and hypoglycemia; led by Novo Nordisk’s Victoza and semaglutide
52 readers recommended
Plus, Lilly invests $5 million! We talk to Dr. Ed Damiano to learn about the new Gen 3 version and upcoming studies.